机构：[1]Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.临床科室血液内科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Institute of Haematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.华中科技大学同济医学院附属协和医院
第一作者机构：[1]Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
通讯作者：
推荐引用方式(GB/T 7714)：
Wang Liang,Mei Heng.Chimeric antigen receptor T-cell therapy, where are we now and where are we heading for[J].European Journal Of Haematology.2024,112(1):4-5.doi:10.1111/ejh.14123.
APA：
Wang Liang&Mei Heng.(2024).Chimeric antigen receptor T-cell therapy, where are we now and where are we heading for.European Journal Of Haematology,112,(1)
MLA：
Wang Liang,et al."Chimeric antigen receptor T-cell therapy, where are we now and where are we heading for".European Journal Of Haematology 112..1(2024):4-5
